MAPK pathway activation in pilocytic astrocytoma
Pilocytic astrocytoma (PA) is the most common tumor of the pediatric central nervous system
(CNS). A body of research over recent years has demonstrated a key role for mitogen …
(CNS). A body of research over recent years has demonstrated a key role for mitogen …
Clinicopathological relevance of BRAF mutations in human cancer
S Pakneshan, A Salajegheh, RA Smith… - Pathology-Journal of …, 2013 - journals.lww.com
BRAF represents one of the most frequently mutated protein kinase genes in human
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …
Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma
H Cin, C Meyer, R Herr, WG Janzarik, S Lambert… - Acta …, 2011 - Springer
Activation of the MAPK signaling pathway has been shown to be a unifying molecular
feature in pilocytic astrocytoma (PA). Genetically, tandem duplications at chromosome 7q34 …
feature in pilocytic astrocytoma (PA). Genetically, tandem duplications at chromosome 7q34 …
The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations
A Von Deimling, A Korshunov, C Hartmann - Brain Pathology, 2011 - Wiley Online Library
For some, glioma biomarkers have been expected to solve common diagnostic problems in
routine neuropathology service caused by insufficient material, technical shortcomings or …
routine neuropathology service caused by insufficient material, technical shortcomings or …
BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants
Recent studies highlight the importance of BRAF alterations resulting in mitogen activated
protein kinase (MAK/ERK) pathway activation in low-grade CNS tumors. We studied 106 low …
protein kinase (MAK/ERK) pathway activation in low-grade CNS tumors. We studied 106 low …
Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
C Horbinski, MN Nikiforova, JM Hagenkord… - Neuro …, 2012 - academic.oup.com
Abstract BRAF rearrangements and BRAF V600E point mutations are recurring events in
pediatric low-grade gliomas. However, their clinical significance, including possible …
pediatric low-grade gliomas. However, their clinical significance, including possible …
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas
The advances of genome‐wide 'discovery platforms' and the increasing affordability of the
analysis of significant sample sizes have led to the identification of novel mutations in brain …
analysis of significant sample sizes have led to the identification of novel mutations in brain …
To BRAF or Not to BRAF: Is That Even a Question Anymore?
C Horbinski - Journal of Neuropathology & Experimental …, 2013 - academic.oup.com
Alterations in BRAF have been discovered in most pediatric low-grade gliomas. Because the
field has moved quickly during the past few years, there is not yet widespread awareness …
field has moved quickly during the past few years, there is not yet widespread awareness …
Current understanding of BRAF alterations in diagnosis, prognosis, and therapeutic targeting in pediatric low-grade gliomas
CL Penman, C Faulkner, SP Lowis, KM Kurian - Frontiers in oncology, 2015 - frontiersin.org
The mitogen-activated protein kinase (MAPK) pathway is known to play a key role in the
initiation and maintenance of many tumors as well as normal development. This often occurs …
initiation and maintenance of many tumors as well as normal development. This often occurs …
Molecular diagnostics of gliomas
MN Nikiforova, RL Hamilton - Archives of pathology & …, 2011 - meridian.allenpress.com
Context.—Gliomas are the most common primary brain tumors of adults and include a
variety of histologic types and morphologies. Histologic evaluation remains the gold …
variety of histologic types and morphologies. Histologic evaluation remains the gold …